<DOC>
	<DOCNO>NCT02875249</DOCNO>
	<brief_summary>Chemotherapy commonly use myeloablative conditioning treatment prepare patient haematopoietic stem cell transplantation ( HSCT ) . Chemotherapy lead several side effect , gastrointestinal ( GI ) mucositis one frequent . Current model GI mucositis pathophysiology generally silent role intestinal microbiome . The aim study identify functional mechanism intestinal microbiome may play key role pathophysiology GI mucositis , investigator apply high throughput DNA-sequencing analysis identify microbes microbial function modulate follow chemotherapy .</brief_summary>
	<brief_title>Intestinal Microbiome Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Participants nonHodgkin 's lymphoma Participants receive myeloablative condition regimen five consecutive day , include highdose Carmustine ( Bischloroethylnitrosourea ) , Etoposide , Aracytine Melphalan . Patients history Inflammatory Bowel Diseases ( IBD ) , expose probiotic , prebiotics broadspectrum antibiotic , administer nasaltube feed parenteral nutrition month prior initiation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>post-antibiotic diarrhea</keyword>
	<keyword>intestinal microbiome</keyword>
</DOC>